Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (296)
- COVID-19 (160)
- Compliance and enforcement (106)
- Safety monitoring and information (100)
- Legislation (81)
- Vaping hub (59)
- Manufacturing (58)
- Import and export (42)
- Labelling and packaging (41)
- Medicinal cannabis hub (29)
- Scheduling (national classification system) (24)
- Sunscreens (20)
- Weight loss products (18)
- Peptide products (11)
- Shortages and supply disruptions (10)
- Committees and advisory bodies (8)
- Cosmetics (6)
- Clinical trials (5)
- Unique Device Identification (UDI) hub (5)
- Fees and payments (2)
- Prescription opioids hub (2)
- Urogynaecological (transvaginal) surgical mesh hub (2)
- Breast implant hub (1)
Search
1213 result(s) found, displaying 426 to 450
-
Regulatory decision noticesArrangement under subsection 7C(1) of the Therapeutic Goods Act 1989
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
News articlesThe Prescribing Medicines in Pregnancy database has now been updated.
-
Regulatory decision noticesDelays in processing timeframes of applications to extend GMP Clearances.
-
Media releasesThe TGA has issued 5 infringement notices to 3 health practitioners for the alleged unlawful importation of unregistered prescription-only medicines.
-
Safety updatesNew warnings for baricitinib, tofacitinib and upadacitinib follow a TGA review of a randomised safety trial called the ORAL Surveillance Study.
-
News articlesThe TGA has updated the Australian Regulatory Guidelines for Sunscreens (ARGS) to align with the data requirements for all ingredients proposed to be included in the Therapeutic Goods (Permissible Ingredients) Determination
-
Safety updatesMedicines Safety Update - Information for health professionals
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Media releasesThe TGA has published a final decision to reduce the maximum size of packs for various paracetamol products.
-
Media releasesFrom 1 June 2023, prescribing of oral ivermectin for ‘off-label’ uses will no longer be limited to specialists such as dermatologists, gastroenterologists and infectious diseases specialists.
-
Regulatory decision noticesListed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2023.
-
Media releasesThe TGA has approved Moderna Australia’s application to transition its COVID-19 vaccine, SPIKEVAX (elasomeran), from provisional to full registration.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Media releasesThe TGA has issued nine infringement notices to three companies and two associated individuals for the alleged unlawful importation of nicotine vaping products.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
BlogFrom 1 July 2023, authorised psychiatrists can prescribe psychedelic medicines to people with specific mental health conditions under strict controls.
-
News articlesEssential Principle 7 now mentions nanomaterials explicitly (see EP 7.7).
-
Media releasesChristopher Ramsey, the Director of AusLabs, Smart Labs and iSARMs, has been sentenced 2 years imprisonment and fined $300,000 for his role in the manufacture, supply and advertising of illegal Selective Androgen Receptor Modulators and nootropic products. Mr Ramsey’s three companies also received significant fines totalling $2,225,000.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
News articlesProvisional registration of Tecentriq (atezolizumab) for the treatment in mTNBC will lapse on 22 March 2023.
-
Regulatory decision noticesMore applications for Good Manufacturing Practice (GMP) clearances can now be assessed under the TGA’s MRA pathway.
-
Safety updatesHealth professionals should check if patients undergoing general anaesthesia have used products containing pholcodine in the previous 12 months.
-
Media releasesThe TGA has issued an infringement notice for $13,320 to Sydney company JSHealth Vitamins Pty Ltd for an alleged breach of the Therapeutic Goods Act 1989.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.